Study: Drug lets obese mice live longer, holds hope for humans

08/19/2011 | New York Times (tiered subscription model), The

A specially designed drug called SRT-1720 has been shown to extend life an average of 44% for obese mice by decreasing fat in the liver and increasing sensitivity to insulin, according to research from the National Institute on Aging. Similar drugs are being tested in human clinical trials, with an eye on creating drugs to help people of all sizes live longer.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL